1. Pharmacologic Considerations in Antimicrobial Therapy, with Emphasis on Pharmacokinetics and Pharmacodynamics: Reviews for the Practicing Clinician

   • P. S. McKinnon
   • V. L. Yu

   Introduction 13 March 2004 Pages: 231 - 232

2. Pharmacokinetic and Pharmacodynamic Issues in the Treatment of Parasitic Infections

   • G. Edwards
   • S. Krishna

   Review 17 March 2004 Pages: 233 - 242

   

3. Pharmacokinetic and Pharmacodynamic Issues in the Treatment of Mycobacterial Infections

   • E. Nuermberger
   • J. Grosset

   Review 13 March 2004 Pages: 243 - 255

   

4. Antifungal Agents: In Vitro Susceptibility Testing, Pharmacodynamics, and Prospects for Combination Therapy

   • A. H. Groll
   • H. Kolve

   Review 11 March 2004 Pages: 256 - 270

   

5. Pharmacokinetic and Pharmacodynamic Issues in the Treatment of Bacterial Infectious Diseases

   • P. S. McKinnon
   • S. L. Davis

   Review 10 March 2004 Pages: 271 - 288

   

6. False-Positive Results and Contamination in Nucleic Acid Amplification Assays: Suggestions for a Prevent and Destroy Strategy

   • A. Borst
   • A. T. A. Box
   • A. C. Fluit

   Review 10 March 2004 Pages: 289 - 299

7. Aventis Pasteur Vaccines Containing Inactivated Hepatitis A Virus: A Compilation of Immunogenicity Data

   • E. Vidor
   • R. Dumas
   • K. Veitch

   Special Article 06 March 2004 Pages: 300 - 309

   

8. Risk Factors For Mortality In Patients With Anaerobic Bacteremia

   • J. R. Wilson
   • A. P. Limaye

   Article 13 March 2004 Pages: 310 - 316

9. Epidemiology of Candidaemia in Europe: Results of 28-Month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance Study

   • A. M. Tortorano
   • J. Peman
   • the ECMM Working Group on Candidaemia

   Article 17 March 2004 Pages: 317 - 322

10. Economic Impact of Candida Colonization and Candida Infection in the Critically Ill Patient

    • P. M. Olaechea
    • M. Palomar
    • the EPCAN Study Group

    Article 13 March 2004 Pages: 323 - 330

11. Efficacy of Directly Observed Treatment of HIV Infection: Experience in AIDS Welfare Homes

    • I. Tinoco
    • J. A. Girón-González
    • A. Bascuñana

    Article 13 March 2004 Pages: 331 - 335

12. Persistent Colonization of Nine Cystic Fibrosis Patients with an Achromobacter (Alcaligenes) xylosoxidans Clone

    • M. Kanellopoulou
    • S. Pournaras
    • A. N. Maniatis

    Concise Article 13 March 2004 Pages: 336 - 339

    

13. Use of Intravenous Polymyxin B During Continuous Venovenous Hemodialysis

    • J. C. Sarria
    • F. Angulo-Pernett
    • A. M. Vidal

    Concise Article 06 March 2004 Pages: 340 - 341

14. African Histoplasmosis Infection with Peritoneal Involvement

    • J. B. Arlet
    • A. Furco-Mazzantini
    • J. M. Molina

    Brief Report 10 March 2004 Pages: 342 - 344

    

15. Mycobacterium Reverse Hybridization Line-Probe Assay Used to Diagnose Disseminated Mycobacterium haemophilum Infection in a Child with Acute Lymphoblastic Leukemia

    • F. Bosma
    • J. M. Deckers-Kocken
    • J. A. Hoogkamp-Korstanje

    Brief Report 06 March 2004 Pages: 345 - 347

16. Failure of Broth-Based Tests to Detect Methicillin-Resistant Staphylococcus aureus in a Clinical Specimen

    • M. J. Schwaber
    • S. Navon-Venezia
    • Y. Carmeli

    Brief Report 13 March 2004 Pages: 348 - 351

    

17. April 2004

    Announcements 19 March 2004 Pages: 352 - 352